Influence of Physical Activity on Hypertension and Cardiac Structure and Function
- PMID: 26277725
- PMCID: PMC4624627
- DOI: 10.1007/s11906-015-0588-3
Influence of Physical Activity on Hypertension and Cardiac Structure and Function
Abstract
The global burden of hypertension is rising and accounts for substantial morbidity and mortality. Lifestyle factors such as diet and physical inactivity contribute to this burden, further highlighting the need for prevention efforts to curb this public health epidemic. Regular physical activity is associated with lower blood pressure, reduced cardiovascular risk, and cardiac remodeling. While exercise and hypertension can both be associated with the development of left ventricular hypertrophy (LVH), the cardiac remodeling from hypertension is pathologic with an associated increase in myocyte hypertrophy, fibrosis, and risk of heart failure and mortality, whereas LVH in athletes is generally non-pathologic and lacks the fibrosis seen in hypertension. In hypertensive patients, physical activity has been associated with paradoxical regression or prevention of LVH, suggesting a mechanism by which exercise can benefit hypertensive patients. Further studies are needed to better understand the mechanisms underlying the benefits of physical activity in the hypertensive heart.
References
-
- Campbell NRC, Lackland DT, Niebylski ML the World Hypertension League and International Society of Hypertension Executive Committees. High Blood Pressure: Why Prevention and Control Are Urgent and Important—A 2014 Fact Sheet From the World Hypertension League and the International Society of Hypertension. J. Clin. Hypertens. 2014;16:551–553. - PMC - PubMed
-
- Cuspidi C, Facchetti R, Bombelli M, Sala C, Tadic M, Grassi G, et al. Prognostic value of left ventricular mass normalized to different body size indexes: findings from the PAMELA population. J. Hypertens. 2015;33:1082–1089. - PubMed
-
- Pierdomenico SD, Lapenna D, Cuccurullo F. Regression of Echocardiographic Left Ventricular Hypertrophy After 2 Years of Therapy Reduces Cardiovascular Risk in Patients with Essential Hypertension. Am. J. Hypertens. 2008;21:464–470. - PubMed
-
- Ruilope LM, Schmieder RE. Left Ventricular Hypertrophy and Clinical Outcomes in Hypertensive Patients. Am. J. Hypertens. 2008;21:500–508. - PubMed
-
- Rodilla E, Pascual JM, Costa JA, Martin J, Gonzalez C, Redon J. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment: J. Hypertens. 2013;31:1683–1691. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
